中国石化新闻网讯 据MRCHUB网站8月2日报道，日前，霍尼韦尔宣布，该公司2023年第二季度的业绩达到或超过了公司的预期。
该公司还上调了2023年全年的有机增长预期（Organic Growth是指公司依托现有资源和业务，通过提高产品质量、销量与服务水平，拓展客户以及扩大市场份额，推进创新与提高生产效率等途径，而获得的销售收入及利润的自然增长）、部门利润率和调整后每股收益(EPS)指导区间。该公司报告称，2023年第二季度销售额同比增长2%，有机销售额同比增长3%，其中商业航空航天、过程解决方案和UOP的有机销售额实现了两位数的增长。
由于安全和生产力解决方案、霍尼韦尔建筑技术和航空航天业务的增长，营业利润率增长达到20.6%；部门利润率增长达到22.4%。2023年第二季度每股收益为2.22美元，同比增长21%，调整后为2.23美元，同比增长6%。
在强劲的净收入和营运资本改善的推动下，运营现金流为14亿美元，自由现金流为11亿美元。2023年全年销售额预计为367亿至373亿美元，有机销售额增长幅度为4%至6%。
目前预计各部门利润率在22.4%至22.6%之间，各部门利润率将增长70至90个基点。调整后的每股收益目前预计在9.05至9.25美元之间，较之前的指导区间低端上涨5美分。
预计经营现金流仍将在49亿至53亿美元之间。自由现金流预计仍将在39亿至43亿美元之间，或51亿至55亿美元之间，不包括2022年第四季度签署的结算的净影响。
郝芬 译自 MRCHUB
原文如下：
Honeywell delivers strong 2Q 2023 results and raises full year 2023 sales
Honeywell announced results for 2Q 2023 that met or exceeded the company's guidance, said the company.
The company also raised its full year 2023 organic growth, segment margin, and adjusted earnings per share (EPS) guidance ranges. The company reported 2Q 2023 sales growth of 2% year-over-year and organic sales growth of 3% year-over-year, led by double-digit organic sales growth in commercial aerospace, process solutions, and UOP.
Operating margin expanded 270 basis points to 20.6% and segment margin expanded by 150 basis points to 22.4%, with expansion in Safety and Productivity Solutions, Honeywell Building Technologies, and Aerospace. EPS for 2Q 2023 was USD2.22, up by 21% year-over-year, and adjusted EPS was USD2.23, up 6% year over year.
Operating cash flow was USD1.4 bn and free cash flow was USD1.1 bn, driven by strong net income and improved working capital. Full year 2023 sales are now expected to be $36.7-37.3 bn with organic sales growth in the range of 4-6%.
Segment margin is now expected to be in the range of 22.4-22.6%, with segment margin expansion of 70-90 basis points. Adjusted EPS is now expected to be in the range of USD9.05-9.25, up by 5 cents on the low end from the prior guidance range.
Operating cash flow is still expected to be in the range of USD4.9-5.3 bn. Free cash flow is still expected to be in the range of USD3.9-4.3 bn, or USD5.1-5.5 bn excluding the net impact of settlements signed in 4Q 2022.
